Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of IDP-115 in patients with rosacea has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• IDP-115

Snippet

Sponsor: Dow Pharmaceutical Sciences | Conditions: Rosacea | Phase 2 | Status: COMPLETED